| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $32.9M | +4.2% | -27.3% |
| Cost of Revenue | $8.4M | +2.3% | -56.2% |
| Gross Profit | $24.5M | +4.9% | -5.9% |
| R&D Expense | $8.5M | +16.2% | -15.8% |
| SG&A Expense | $12.9M | -5.4% | -2.0% |
| Operating Income | -$4.9M | -6.2% | +63.1% |
| Pre-tax Income | $12.4M |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $55.0M | +50.7% | -0.0% |
| Short-term Investments | $22.2M | -57.1% | -64.0% |
| Accounts Receivable | $12.2M | -18.5% | -23.2% |
| Current Assets | $116.0M | -8.5% | -20.8% |
| Total Assets | $189.6M | +3.5% | +1.8% |
| Current Liabilities |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $10.5M | — | — |
| Investing Cash Flow | $19.8M | — | — |
| Financing Cash Flow | -$15.0M | — | — |
| +444.9% |
| +576.7% |
| Income Tax | $27K | -34.1% | +50.0% |
| Net Income | $12.5M | +288.6% | +612.6% |
| EPS (Basic) | $0.03 | +175.0% | +200.0% |
| EPS (Diluted) | $0.02 | +150.0% | +166.7% |
| $45.7M |
| -13.4% |
| +0.9% |
| Long-term Debt | $0 | — | — |
| Total Liabilities | $47.3M | -14.7% | -0.5% |
| Stockholders' Equity | -$12.5M | +44.7% | +74.8% |